Amyris and IDRI Announce Agreement to Explore Testing and Development of Amyris Materials for Use in Vaccine Adjuvant Formulations

September 9th, 2015|Press Releases|

EMERYVILLE, Calif. and SEATTLE, Wash. (September 9, 2015) Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, and IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that uses biotechnology to create new diagnostics, drugs and vaccines, today announced an [...]